David Moatazedi sold Evolus Inc. ($EOLS) shares on the open market six times over the past year, totaling nearly $3 million. His most recent sale occurred on December 22, 2025. These sales rank 2,750th among 11,678 individual insiders, below the average sale value of $8.6 million and average of 6.4 transactions per insider. Moatazedi made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 13669 | $4.75 | 604,700.0000 | 64,819,784 | 2.21% | 0.02% |
| March 16, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Common Stock | 67489 | $0.00 | 735,089.0000 | 64,819,784 | 10.11% | 0.10% |
| March 17, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 116720 | $4.89 | 618,369.0000 | 64,819,784 | 15.88% | 0.18% |
| March 16, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Performance Restricted Stock Units | 67489 | $0.00 | 67,488.0000 | 64,819,784 | 50.00% | 0.10% |
| Feb. 17, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Common Stock | 313212 | $0.00 | 667,600.0000 | 64,819,784 | 88.38% | 0.48% |
| Feb. 17, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Stock Option (Right to Buy) | 457541 | $0.00 | 457,541.0000 | 64,819,784 | 9999.99% | 0.71% |
| Feb. 17, 2026 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Performance Restricted Stock Units | 626424 | $0.00 | 626,424.0000 | 64,819,784 | 9999.99% | 0.97% |
| Dec. 12, 2025 | BIOMERICA INC | $BMRA | MOATAZEDI DAVID | Director | A | Common stock | 20000 | $0.00 | 30,625.0000 | 2,815,410 | 188.24% | 0.71% |
| Dec. 22, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 10539 | $7.15 | 354,388.0000 | 64,819,784 | 2.89% | 0.02% |
| June 13, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 111323 | $10.05 | 381,509.0000 | 63,586,753 | 22.59% | 0.18% |
| June 16, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 16582 | $9.89 | 364,927.0000 | 63,586,753 | 4.35% | 0.03% |
| May 12, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 15787 | $9.87 | 492,832.0000 | 63,586,753 | 3.10% | 0.02% |
| March 27, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 6251 | $12.40 | 508,619.0000 | 63,586,753 | 1.21% | 0.01% |
| March 18, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 103376 | $13.26 | 514,870.0000 | 63,586,753 | 16.72% | 0.16% |
| March 7, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Common Stock | 95399 | $0.00 | 618,246.0000 | 63,586,753 | 18.25% | 0.15% |
| March 7, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Performance Restricted Stock Units | 190799 | $0.00 | 190,799.0000 | 63,586,753 | 9999.99% | 0.30% |
| March 7, 2025 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Stock Option (Right to Buy) | 135925 | $0.00 | 135,925.0000 | 63,586,753 | 9999.99% | 0.21% |
| Dec. 23, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 10502 | $10.85 | 522,847.0000 | 0 | 1.97% | 0.00% |
| Dec. 13, 2024 | BIOMERICA INC | $BMRA | MOATAZEDI DAVID | Director | A | Common stock | 85000 | $0.31 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 140214 | $12.73 | 533,349.0000 | 0 | 20.82% | 0.00% |
| June 6, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Common Stock | 175940 | $7.28 | 709,289.0000 | 0 | 32.99% | 0.00% |
| June 6, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 175940 | $12.59 | 533,349.0000 | 0 | 24.81% | 0.00% |
| June 5, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Stock Option (Right to Buy) | 155278 | $0.00 | 155,281.0000 | 0 | 50.00% | 0.00% |
| June 6, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Stock Option (Right to Buy) | 175940 | $0.00 | 1,006,079.0000 | 0 | 14.88% | 0.00% |
| June 5, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 155278 | $12.92 | 533,349.0000 | 0 | 22.55% | 0.00% |
| June 5, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | M | Common Stock | 155278 | $5.46 | 688,627.0000 | 0 | 29.11% | 0.00% |
| May 10, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 16051 | $12.72 | 673,563.0000 | 0 | 2.33% | 0.00% |
| March 27, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 6236 | $13.86 | 689,614.0000 | 0 | 0.90% | 0.00% |
| March 19, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 96566 | $13.92 | 695,850.0000 | 0 | 12.19% | 0.00% |
| Feb. 22, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | S | Common Stock | 7706 | $13.08 | 792,416.0000 | 0 | 0.96% | 0.00% |
| Feb. 21, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Common Stock | 61202 | $0.00 | 800,122.0000 | 0 | 8.28% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Stock Option (Right to Buy) | 181460 | $0.00 | 181,460.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Performance Restricted Stock Units | 134977 | $0.00 | 134,977.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | MOATAZEDI DAVID | See Remarks | A | Common Stock | 134976 | $0.00 | 738,920.0000 | 0 | 22.35% | 0.00% |
| Dec. 13, 2023 | BIOMERICA INC | $BMRA | MOATAZEDI DAVID | Director | A | Non-qualified stock option | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2023 | BIOMERICA INC | $BMRA | MOATAZEDI DAVID | Director | A | Non-qualified stock option | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2023 | BIOMERICA INC | $BMRA | MOATAZEDI DAVID | Director | A | Non-qualified stock option | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |